| Total Voting Rights | 01-Dec-2025 | 07:00 | RNS |
| Holding(s) in Company | 03-Nov-2025 | 16:55 | RNS |
| Total Voting Rights | 03-Nov-2025 | 07:00 | RNS |
| Director/PDMR Shareholding | 20-Oct-2025 | 17:54 | RNS |
| Director/PDMR Shareholding | 20-Oct-2025 | 17:13 | RNS |
| Board Change | 20-Oct-2025 | 10:17 | RNS |
| Director/PDMR Shareholding | 16-Oct-2025 | 07:00 | RNS |
| Acquisition of US viral vector facility | 07-Oct-2025 | 07:00 | RNS |
| Total Voting Rights | 01-Oct-2025 | 07:00 | RNS |
| Interim Results for 6 months ended 30 June 2025 | 23-Sep-2025 | 07:00 | RNS |
| Total Voting Rights | 01-Sep-2025 | 07:00 | RNS |
| PDMR Dealings | 22-Aug-2025 | 15:36 | RNS |
| Holding(s) in Company | 21-Aug-2025 | 10:24 | RNS |
| Admission of Shares and Total Voting Rights | 20-Aug-2025 | 07:00 | RNS |
| PDMR Dealings | 15-Aug-2025 | 13:45 | RNS |
| Currency | UK Pounds |
| Share Price | 619.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 682.00 |
| 52 Week Low | 232.50 |
| Volume | 134,750 |
| Shares Issued | 120.54m |
| Market Cap | £746.14m |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 4 |
| Buy | 2 |
| Neutral | 4 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 10 |

| No dividends found |
| Time | Volume / Share Price |
| 16:37 | 1,969 @ 615.00p |
| 16:47 | 1,257 @ 618.81p |
| 16:37 | 5,841 @ 615.00p |
| 16:37 | 1,969 @ 615.00p |
| 16:35 | 24,082 @ 619.00p |
| Chair | Roch Doliveux |
| CEO | Frank Mathias |
| CFO | Lucinda (Lucy) Crabtree |
You are here: research